Matrix metalloproteinases and matrix receptors in progression and reversal of kidney disease: therapeutic perspectives  Pierre Ronco, Christos Chatziantoniou 

Slides:



Advertisements
Similar presentations
Renal Stress Testing in the Assessment of Kidney Disease Lakhmir S. Chawla, Claudio Ronco Kidney International Reports Volume 1, Issue 1, Pages (May.
Advertisements

Melamine toxicity: one more culprit in calcium kidney lithiasis
Combination therapy with ACE inhibitors and angiotensin II receptor blockers in chronic renal disease: New therapeutic world beyond blood pressure reduction 
Renal manifestations in Fabry disease and therapeutic options
Propofol-related green urine
Anemia management in chronic kidney disease
Mitchell H. Rosner, W. Kline Bolton  Kidney International 
Volume 83, Issue 3, Pages (March 2013)
Stem cells for kidney repair: useful tool for acute renal failure?
ESA and iron therapy in chronic kidney disease: a balance between patient safety and hemoglobin target  Szu-Chun Hung, Der-Cherng Tarng  Kidney International 
Hyun Gyu Lee, Hoon Young Choi, Jong-Sup Bae  Kidney International 
Status of chronic kidney disease prevention programs: International Federation of Kidney Foundation Members 2005/2007  Joanna M. Smith, Susan A. Mott,
Reassessment of the care of the patient with chronic kidney disease
Progression of renal failure and hypertensive nephrosclerosis
John P. Middleton, Patrick H. Pun  Kidney International 
Volume 77, Issue 1, Pages 6-8 (January 2010)
Burden of chronic kidney disease: North Africa
Volume 58, Issue 1, Pages (July 2000)
Volume 85, Issue 3, Pages (March 2014)
Jeffrey C. Fink, Glenn M. Chertow  Kidney International 
Steven G. Coca, Swathi Singanamala, Chirag R. Parikh 
Volume 86, Issue 4, Pages (October 2014)
Yasemin Sirin, Hermann Pavenstädt  Kidney International 
Volume 70, Issue 7, Pages (October 2006)
Comorbidity and confounding in end-stage renal disease
Volume 74, Issue 3, Pages (August 2008)
The new role of calcimimetics as vasculotropic agents
Punit Yadav, Nelson Leung, Paul W. Sanders, Paul Cockwell 
Volume 70, Issue 11, Pages (December 2006)
Volume 79, Pages S20-S23 (April 2011)
Use of vitamin D in chronic kidney disease patients
Saulo Klahr, Jeremiah J. Morrissey  Kidney International 
Volume 70, Issue 12, Pages (December 2006)
Ferruh Artunc, Friedhelm Hildebrandt, Kerstin Amann 
Melamine toxicity: one more culprit in calcium kidney lithiasis
Qingqing Wei, Zheng Dong  Kidney International 
Fructose intake as a risk factor for kidney stone disease
The promise of biomarkers for personalized renal cancer care
Volume 73, Issue 12, Pages (June 2008)
Macrophages and hypoxia in human chronic kidney disease
Volume 76, Issue 6, Pages (September 2009)
Extracorporeal therapy in sepsis: are we there yet?
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Tilman B. Drüeke, Ziad A. Massy  Kidney International 
Calcium sensing in podocytes
Volume 87, Issue 1, Pages (January 2015)
Volume 76, Issue 8, Pages (October 2009)
The global challenge of chronic kidney disease
Nephrology Crossword: Glomerulonephritis
Juan Camilo Duque, Roberto I. Vazquez-Padron  Kidney International 
A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease  S. Susan Hedayati, Venkata Yalamanchili,
Unilateral renal cystic disease
Apoptosis in ischemic renal injury: Roles of GTP depletion and p53
Volume 73, Issue 9, Pages (May 2008)
Vitamin D in chronic kidney disease: is the jury in?
Does equal care give equal outcomes?
Pablo A. Ureña Torres, Marc De Broe  Kidney International 
Volume 80, Issue 10, Pages (November 2011)
Is complement a target for therapy in renal disease?
Tobias Breidthardt, Alexandre Mebazaa, Christian E. Mueller 
Volume 75, Issue 7, Pages (April 2009)
Volume 75, Issue 6, Pages (March 2009)
T cells and T-cell receptors in acute renal failure
Volume 70, Issue 10, Pages (November 2006)
In chronic kidney disease staging the use of the chronicity criterion affects prognosis and the rate of progression  B.O. Eriksen, O.C. Ingebretsen  Kidney.
Volume 74, Issue 10, Pages (November 2008)
Volume 72, Issue 8, Pages (October 2007)
Sugar-sweetened beverages and chronic disease
Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies  Lei-Shi Li, Zhi-Hong Liu  Kidney International 
Presentation transcript:

Matrix metalloproteinases and matrix receptors in progression and reversal of kidney disease: therapeutic perspectives  Pierre Ronco, Christos Chatziantoniou  Kidney International  Volume 74, Issue 7, Pages 873-878 (October 2008) DOI: 10.1038/ki.2008.349 Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 1 Proposed involvement of DDR1 in chronic renal disease: AngII induces collagen synthesis simultaneously and increases DDR1 expression; collagen binds DDR1 and induces phosphorylation of its intracellular part. This activation of DDR1 stimulates the p38 pathway, which in turn leads to cytokine activation. Cytokine release further stimulates collagen synthesis and DDR1 expression. Thus, DDR1 participates in a positive cross talk between inflammation and ECM synthesis, which ultimately leads to chronic renal failure. Kidney International 2008 74, 873-878DOI: (10.1038/ki.2008.349) Copyright © 2008 International Society of Nephrology Terms and Conditions